Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study.

Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study.

CD73 dephosphorylates adenosine monophosphate to adenosine that is an anti-inflammatory molecule inhibiting immune activation and vascular leakage. Therefore, CD73 could be an interesting mediator both in sepsis and acute kidney injury (AKI). We aimed to explore the soluble CD73 (sCD73) levels and t...

Full description

Bibliographic Details
Main Authors: Suvi T Vaara, Maija Hollmén, Anna-Maija Korhonen, Mikael Maksimow, Tero Ala-Kokko, Marko Salmi, Sirpa Jalkanen, Ville Pettilä, FINNAKI Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5061395?pdf=render

Internet

http://europepmc.org/articles/PMC5061395?pdf=render

Similar Items